Short- and long-term use of octreotide in the treatment of congenital hyperinsulinism
Open Access
- 31 October 1993
- journal article
- Published by Elsevier BV in The Journal of Pediatrics
- Vol. 123 (4), 637-643
- https://doi.org/10.1016/s0022-3476(05)80969-2
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Management of hyperinsulinism in infantsThe Journal of Pediatrics, 1991
- Familial and sporadic hyperinsulinism: Histopathologic findings and segregation analysis support a single autosomal recessive disorderThe Journal of Pediatrics, 1991
- Linear growth during long-term treatment with somatostatin analog (SMS 201-995) for persistent hyperinsulinemic hypoglycemia of infancyThe Journal of Pediatrics, 1990
- Long-acting somatostatin analog in refractory neonatal hypoglycemia: Follow-up informationThe Journal of Pediatrics, 1988
- Long-Term Treatment of an Infant with Nesidioblastosis Using a Somatostatin AnalogueNew England Journal of Medicine, 1987
- Short-Term Management of Nesidioblastosis Using the Somatostatin Analogue SMS 201–995New England Journal of Medicine, 1987
- Treatment of insulin excess by continuous subcutaneous infusion of somatostatin and glucagon in an infantThe Journal of Pediatrics, 1985
- SMS 201–995: A very potent and selective octapeptide analogue of somatostatin with prolonged actionLife Sciences, 1982
- Somatostatin treatment of insulin excess due to β-cell adenoma in a neonateThe Journal of Pediatrics, 1980
- Hypoglycemia of Infancy and NesidioblastosisNew England Journal of Medicine, 1977